Clinical Trial Update: Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis

View source ↗

Summary

An update on the Onyx zotarolimus-eluting stent for coronary artery disease, focusing on its effect and efficacy. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Onyx Zotarolimus-eluting Stent (zotarolimus-eluting stent)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Coronary Artery Disease, Acute Coronary Syndrome | Status: UNKNOWN